EMR
71
-3
TSN
50
-2
MCD
52
-5
WHR
65
-5
SLG
57
-3
PPG
57
-3
SWK
50
-5
AMT
37
3
NEE
54
7
STI
45
26
MSI
72
-3
AIZ
82
2
CL
54
3
AXP
67
-2
SPG
60
2
BBY
52
6
DHI
44
-3
LMT
30
-2
AEP
54
6
BMY
55
-8
EMR
71
-3
TSN
50
-2
MCD
52
-5
WHR
65
-5
SLG
57
-3
PPG
57
-3
SWK
50
-5
AMT
37
3
NEE
54
7
STI
45
26
MSI
72
-3
AIZ
82
2
CL
54
3
AXP
67
-2
SPG
60
2
BBY
52
6
DHI
44
-3
LMT
30
-2
AEP
54
6
BMY
55
-8
Financhill
Back

ASA Gold And Precious Metals Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
52

ASA
ASA Gold And Precious Metals

Last Price:
19.51
Seasonality Move:
6.64%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
52
ASA Gold And Precious Metals (ASA) is a Buy

Is ASA Gold And Precious Metals a Buy, Sell or Hold?

  • The current ASA Gold And Precious Metals [ASA] share price is $19.47. The Score for ASA is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • ASA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ASA Stock Price Chart

What is ASA Gold And Precious Metals's stock price today?

  • The ASA Gold And Precious Metals share price today is $19.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASA is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

ASA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.38 Sell
Relative Strength Index (14 RSI): 28.39 Sell
Chaikin Money Flow: -41693 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.56 - 22.46) Sell
Bollinger Bands (100): (18.59 - 21.31) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

ASA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.43 Sell
20-day SMA: 21.49 Sell
50-day SMA: 20.99 Sell
200-day SMA: 18.15 Buy
8-day EMA: 20.28 Sell
20-day EMA: 20.94 Sell
50-day EMA: 20.81 Sell
200-day EMA: 18.7 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

ASA Gold And Precious Metals Earnings Growth & ASA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

ASA Gold And Precious Metals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):